Trial Details

COMPLETED
Basic Information
Clinical ID c157
Identifier NCT02453776
Trial Title Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Disease
Interventions DRUG: PRECISION dosing Infliximab
Participant Information
Sponsor Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
City Amsterdam
Country/Region Netherlands
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2025-05-15
Primary Completion Date 2025-12-18
Completion Date 2025-12-18